Exercise Duration Models, in Middle-aged Men

February 17, 2017 updated by: Mohammadreza Rezaeipour, MD, PhD, P.L.Shupik National Medical Academy of Post-Graduate Education

The Study of Various Models of Exercise Duration on Weight Loss and Lipid Profile in Sedentary Overweight/Obese Middle-aged Men

Duration of exercise is an important factor among the medical guides for weight loss. However, there is still little knowledge about other its models in middle-aged and older men. The present study aimed to determine the effects of the interval training on weight loss and lipid profile, and to compare its efficiency with the continuous training.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Participants included sedentary men (age 45-75 years) with overweight or obesity (n= 82). They were randomly divided into two groups including continuous exercise, and interval exercise. The weight assessment parameters including change in weight and body composition, blood sample tests were performed pre- and three month post-intervention.

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Sedentary lifestyle
  • Good Health
  • Weight stability

Exclusion Criteria:

Abnormality or history of Disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: continuous training group
With the continuous training program
Other: Continuous training
Study group I (42 participants) received the continuous training.
Other Names:
  • group I
Experimental: interval training group
With the interval training program
Other: The interval training
Study group II (40 participants) received the interval training.
Other Names:
  • group II

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
4-item
Time Frame: 3 months
weight, lipid profile (HDL, LDL, Cholesterol)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
4-item
Time Frame: 3 months
weight, lipid profile (HDL, LDL, Cholesterol)
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

P.L.Shupik National Medical Academy of Post-Graduate Education

Investigators

  • Principal Investigator: Mohammadreza Rezaeipour, M.D., PhD., Member of Scientific Board in Physical Education and Sport Sciences of Sistan and Baluchestan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2014

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

June 21, 2013

First Submitted That Met QC Criteria

February 5, 2017

First Posted (Estimate)

February 8, 2017

Study Record Updates

Last Update Posted (Actual)

February 20, 2017

Last Update Submitted That Met QC Criteria

February 17, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • No Grant-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Loss

Clinical Trials on Continuous training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe